These results indicate that EGFR and HER2 overexpression and gene amplification are frequently observed in ESCC, strongly suggesting that signaling involving these factors may play important biological roles and may be useful molecular targets in ESCC. The gene discussed is ERBB2; the disease is esophageal squamous cell carcinoma.